Skip to content
Trial Eligibility
Menu

Clinical Trials Recruiting near Charlottesville, VA

438 clinical trials have a recruiting site within 25 miles of Charlottesville, Virginia, according to ClinicalTrials.gov data processed . The closest recruiting site is within 1 mile of the city center.

Distances are measured from the city center to each site's city, so they are approximate.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Studies enrolling near Charlottesville

Showing 30 studies, nearest first.
  1. MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

    NCT03072927

    • Observational
    • Ages 18 years and older
    • Sex: All
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 25 mi
  2. Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

    NCT07222566

    • Phase 3
    • Ages 18 years and older
    • Sex: All
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 25 mi
  3. Randomized Study in Children and Adolescents With Migraine: Acute Treatment

    NCT04649242

    • Phase 3
    • Ages 6 to 17 years
    • Sex: All
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 25 mi
  4. Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

    NCT04743141

    • Phase 3
    • Ages 6 to 17 years
    • Sex: All
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 25 mi
  5. Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

    NCT06952660

    • Phase 4
    • Ages 18 years and older
    • Sex: Female
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 25 mi
  6. This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

    NCT07028853

    • Phase 3
    • Ages 18 years and older
    • Sex: Male
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 25 mi
  7. A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

    NCT04831580

    • Interventional
    • Ages 18 years and older
    • Sex: Female
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 25 mi
  8. Role of Estrogen on Skeletal Outcomes in FHA

    NCT07010146

    • Phase 2
    • Ages 14 to 30 years
    • Sex: Female
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 25 mi
  9. A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

    NCT07216703

    • Phase 3
    • Ages 18 years and older
    • Sex: Female
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 25 mi
  10. Spinal Cord Injury Registry - North American Clinical Trials Network

    NCT00178724

    • Observational
    • Ages 18 years and older
    • Sex: All
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 25 mi
  11. Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

    NCT00271180

    • Observational
    • Ages Any age
    • Sex: All
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 25 mi
  12. Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

    NCT00929006

    • Early Phase 1
    • Ages 10 to 17 years
    • Sex: Female
    • Accepts healthy volunteers
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 25 mi
  13. Maternal Newborn Health Registry

    NCT01073475

    • Observational
    • Ages Any age
    • Sex: All
    • Accepts healthy volunteers
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 25 mi
  14. A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

    NCT01351545

    • Observational
    • Ages Any age
    • Sex: All
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 25 mi
  15. Product Surveillance Registry

    NCT01524276

    • Observational
    • Ages Any age
    • Sex: All
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 25 mi
  16. Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

    NCT01574053

    • Observational
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 25 mi
  17. Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation

    NCT01656603

    • Phase 2
    • Ages Any age
    • Sex: All
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 25 mi
  18. Project: Every Child for Younger Patients With Cancer

    NCT02402244

    • Observational
    • Ages Up to 25 years
    • Sex: All
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 25 mi
  19. Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs

    NCT02493478

    • Observational
    • Ages Any age
    • Sex: All
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 25 mi
  20. Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

    NCT02523014

    • Phase 2
    • Ages 18 years and older
    • Sex: All
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 25 mi
  21. COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

    NCT02744677

    • Interventional
    • Ages Any age
    • Sex: All
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 25 mi
  22. Gastroschisis Outcomes of Delivery (GOOD) Study

    NCT02774746

    • Interventional
    • Ages 18 years and older
    • Sex: Female
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 25 mi
  23. National Collaborative to Improve Care of Children With Complex Congenital Heart Disease

    NCT02852031

    • Observational
    • Ages Up to 15 months
    • Sex: All
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 25 mi
  24. A Randomized Multicenter Study for Isolated Skin Vasculitis

    NCT02939573

    • Phase 2
    • Ages 18 years and older
    • Sex: All
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 25 mi
  25. Transformative Research in Diabetic Nephropathy

    NCT02986984

    • Observational
    • Ages 18 to 100 years
    • Sex: All
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 25 mi
  26. Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

    NCT03004326

    • Observational
    • Ages 5 years and older
    • Sex: All
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 25 mi
  27. Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

    NCT03067181

    • Phase 3
    • Ages Any age
    • Sex: All
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 25 mi
  28. Hyperandrogenemia and Altered Day-night LH Pulse Patterns

    NCT03068910

    • Early Phase 1
    • Ages 10 to 17 years
    • Sex: Female
    • Accepts healthy volunteers
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 25 mi
  29. Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

    NCT03127267

    • Phase 3
    • Ages 18 to 81 years
    • Sex: All
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 25 mi
  30. International Registry for Men With Advanced Prostate Cancer (IRONMAN)

    NCT03151629

    • Observational
    • Ages 21 years and older
    • Sex: Male
    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 25 mi

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.